| John Calvin Gower, CAA | |
|
100 Hospital Dr, Bennington, VT 05201-5004 | |
| (802) 447-4535 | |
| (802) 447-4537 |
| Full Name | John Calvin Gower |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology Assistant |
| Experience | 27 Years |
| Location | 100 Hospital Dr, Bennington, Vermont |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962514406 | NPI | - | NPPES |
| 1011952 | Medicaid | VT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367H00000X | Anesthesiologist Assistant | AAA0000006 (Vermont) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Fisher-titus Hospital | Norwalk, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| A4 Of Ohio Llc | 3971837188 | 27 |
| Anesthesia Associates Of Cincinnati, Inc | 4789598509 | 115 |
News Archive
A study led by a team of scientists from the Cancer Science Institute of Singapore at the National University of Singapore has identified new genetic alterations contributing to the onset of Acute Promyelocytic Leukemia (APL).
Pfizer Inc. today announced the European Commission has approved TRAZIMERA, a biosimilar to Herceptin (trastuzumab), for the treatment of human epidermal growth factor overexpressing breast cancer and HER2 overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma.
Scientists at the IFOM-IEO Campus have revealed the function of a protein that is indispensable for passing on an accurate copy of the genome from mother to daughter cells. This study, published in Cell, opens up new avenues of research to reduce the toxicity of chemotherapy in the treatment of cancer.
The daily toll of COVID-19, as measured by new cases and the growing number of deaths, overlooks a shadowy set of casualties: the rising risk of mental health problems among health care professionals working on the frontlines of the pandemic.
› Verified 8 days ago
| Entity Name | Anesthesia Associates Of Cincinnati, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316945173 PECOS PAC ID: 4789598509 Enrollment ID: O20031117000374 |
News Archive
A study led by a team of scientists from the Cancer Science Institute of Singapore at the National University of Singapore has identified new genetic alterations contributing to the onset of Acute Promyelocytic Leukemia (APL).
Pfizer Inc. today announced the European Commission has approved TRAZIMERA, a biosimilar to Herceptin (trastuzumab), for the treatment of human epidermal growth factor overexpressing breast cancer and HER2 overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma.
Scientists at the IFOM-IEO Campus have revealed the function of a protein that is indispensable for passing on an accurate copy of the genome from mother to daughter cells. This study, published in Cell, opens up new avenues of research to reduce the toxicity of chemotherapy in the treatment of cancer.
The daily toll of COVID-19, as measured by new cases and the growing number of deaths, overlooks a shadowy set of casualties: the rising risk of mental health problems among health care professionals working on the frontlines of the pandemic.
› Verified 8 days ago
| Entity Name | University Of Toledo Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942296033 PECOS PAC ID: 8729983416 Enrollment ID: O20031205000019 |
News Archive
A study led by a team of scientists from the Cancer Science Institute of Singapore at the National University of Singapore has identified new genetic alterations contributing to the onset of Acute Promyelocytic Leukemia (APL).
Pfizer Inc. today announced the European Commission has approved TRAZIMERA, a biosimilar to Herceptin (trastuzumab), for the treatment of human epidermal growth factor overexpressing breast cancer and HER2 overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma.
Scientists at the IFOM-IEO Campus have revealed the function of a protein that is indispensable for passing on an accurate copy of the genome from mother to daughter cells. This study, published in Cell, opens up new avenues of research to reduce the toxicity of chemotherapy in the treatment of cancer.
The daily toll of COVID-19, as measured by new cases and the growing number of deaths, overlooks a shadowy set of casualties: the rising risk of mental health problems among health care professionals working on the frontlines of the pandemic.
› Verified 8 days ago
| Entity Name | Southwest Anesthesia Services Psc, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235188129 PECOS PAC ID: 3779483631 Enrollment ID: O20040109000000 |
News Archive
A study led by a team of scientists from the Cancer Science Institute of Singapore at the National University of Singapore has identified new genetic alterations contributing to the onset of Acute Promyelocytic Leukemia (APL).
Pfizer Inc. today announced the European Commission has approved TRAZIMERA, a biosimilar to Herceptin (trastuzumab), for the treatment of human epidermal growth factor overexpressing breast cancer and HER2 overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma.
Scientists at the IFOM-IEO Campus have revealed the function of a protein that is indispensable for passing on an accurate copy of the genome from mother to daughter cells. This study, published in Cell, opens up new avenues of research to reduce the toxicity of chemotherapy in the treatment of cancer.
The daily toll of COVID-19, as measured by new cases and the growing number of deaths, overlooks a shadowy set of casualties: the rising risk of mental health problems among health care professionals working on the frontlines of the pandemic.
› Verified 8 days ago
| Entity Name | Ohio Anesthesia Group, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639348113 PECOS PAC ID: 9537222138 Enrollment ID: O20090108000069 |
News Archive
A study led by a team of scientists from the Cancer Science Institute of Singapore at the National University of Singapore has identified new genetic alterations contributing to the onset of Acute Promyelocytic Leukemia (APL).
Pfizer Inc. today announced the European Commission has approved TRAZIMERA, a biosimilar to Herceptin (trastuzumab), for the treatment of human epidermal growth factor overexpressing breast cancer and HER2 overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma.
Scientists at the IFOM-IEO Campus have revealed the function of a protein that is indispensable for passing on an accurate copy of the genome from mother to daughter cells. This study, published in Cell, opens up new avenues of research to reduce the toxicity of chemotherapy in the treatment of cancer.
The daily toll of COVID-19, as measured by new cases and the growing number of deaths, overlooks a shadowy set of casualties: the rising risk of mental health problems among health care professionals working on the frontlines of the pandemic.
› Verified 8 days ago
| Entity Name | A4 Of Ohio Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255996567 PECOS PAC ID: 3971837188 Enrollment ID: O20190621001667 |
News Archive
A study led by a team of scientists from the Cancer Science Institute of Singapore at the National University of Singapore has identified new genetic alterations contributing to the onset of Acute Promyelocytic Leukemia (APL).
Pfizer Inc. today announced the European Commission has approved TRAZIMERA, a biosimilar to Herceptin (trastuzumab), for the treatment of human epidermal growth factor overexpressing breast cancer and HER2 overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma.
Scientists at the IFOM-IEO Campus have revealed the function of a protein that is indispensable for passing on an accurate copy of the genome from mother to daughter cells. This study, published in Cell, opens up new avenues of research to reduce the toxicity of chemotherapy in the treatment of cancer.
The daily toll of COVID-19, as measured by new cases and the growing number of deaths, overlooks a shadowy set of casualties: the rising risk of mental health problems among health care professionals working on the frontlines of the pandemic.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John Calvin Gower, CAA 3355 Glendale Ave., 3rd Floor, Toledo, OH 43614-4361 Ph: (419) 383-3556 | John Calvin Gower, CAA 100 Hospital Dr, Bennington, VT 05201-5004 Ph: (802) 447-4535 |
News Archive
A study led by a team of scientists from the Cancer Science Institute of Singapore at the National University of Singapore has identified new genetic alterations contributing to the onset of Acute Promyelocytic Leukemia (APL).
Pfizer Inc. today announced the European Commission has approved TRAZIMERA, a biosimilar to Herceptin (trastuzumab), for the treatment of human epidermal growth factor overexpressing breast cancer and HER2 overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma.
Scientists at the IFOM-IEO Campus have revealed the function of a protein that is indispensable for passing on an accurate copy of the genome from mother to daughter cells. This study, published in Cell, opens up new avenues of research to reduce the toxicity of chemotherapy in the treatment of cancer.
The daily toll of COVID-19, as measured by new cases and the growing number of deaths, overlooks a shadowy set of casualties: the rising risk of mental health problems among health care professionals working on the frontlines of the pandemic.
› Verified 8 days ago
Kelsey Buran, Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 100 Hospital Dr, Bennington, VT 05201 Phone: 802-442-6361 | |
Kimberley Monnet, Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 100 Hospital Dr, Bennington, VT 05201 Phone: 248-635-2416 | |
Mary Campbell, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 100 Hospital Dr, Bennington, VT 05201 Phone: 802-442-6361 | |
Suela Hysenaj, Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 100 Hospital Dr, Bennington, VT 05201 Phone: 802-442-6361 | |
Gary Moelich, AA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 100 Hospital Drive, Bennington, VT 05201 Phone: 802-442-6361 | |
Timothy Scott Snyder, AA-C Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 100 Hospital Dr, Bennington, VT 05201 Phone: 802-442-6361 | |
Cody Holloway, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 100 Hospital Dr, Bennington, VT 05201 Phone: 530-640-0220 |